Stocks and Investing
Stocks and Investing
Mon, January 8, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, January 5, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Reni Benjamin Downgraded (ALLO) to Hold on, Jan 5th, 2024
Reni Benjamin of JMP Securities, Downgraded "Allogene Therapeutics, Inc." (ALLO) to Hold on, Jan 5th, 2024.
Reni has made no other calls on ALLO in the last 4 months.
There are 3 other peers that have a rating on ALLO. Out of the 3 peers that are also analyzing ALLO, 0 agree with Reni's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Reni
- Samantha Semenkow of "Citigroup" Initiated at Strong Buy and Held Target at $7 on, Friday, December 8th, 2023
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $12 on, Wednesday, November 15th, 2023
- Brian Cheng of "JP Morgan" Maintained at Buy with Decreased Target to $9 on, Monday, September 25th, 2023
Contributing Sources